Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding preferences for a mindfulness-based stress management program among caregivers of hematopoietic cell transplant patients.

Complementary therapies in clinical practice·2018
Same author

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Directionality of non-permissive HLA-DPB1 T-cell epitope group mismatches does not improve clinical risk stratification in 8/8 matched unrelated donor hematopoietic cell transplantation.

Bone marrow transplantation·2017
Same author

Predictors of overall survival among patients treated with sirolimus/tacrolimus vs methotrexate/tacrolimus for GvHD prevention.

Bone marrow transplantation·2017
Same author

Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.

Bone marrow transplantation·2016
Same author

Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016

Related Experiment Video

Updated: May 9, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Biologic markers of chronic GVHD.

J Pidala1, M Sarwal2, S Roedder3

  • 1Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA.

Bone Marrow Transplantation
|July 23, 2013
PubMed
Summary

Biologic markers for chronic graft-versus-host disease (GVHD) are crucial for understanding, predicting, and treating this condition. Research highlights specific immune cell and mediator alterations associated with chronic GVHD development and progression.

More Related Videos

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

Related Experiment Videos

Last Updated: May 9, 2026

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (GVHD) is a significant complication following hematopoietic cell transplantation (HCT).
  • Understanding the biologic markers of chronic GVHD is essential for improving patient outcomes.
  • Current research focuses on identifying predictive and diagnostic markers, but synthesis and validation are limited.

Purpose of the Study:

  • To synthesize and validate biologic markers associated with chronic GVHD.
  • To identify molecular targets for novel therapeutic interventions.
  • To facilitate advances in the clinical management of chronic GVHD.

Main Methods:

  • Review and synthesis of existing studies on chronic GVHD biologic markers.
  • Analysis of immune cell populations (e.g., NK, Treg, DC2, T cells) and their alterations.
  • Evaluation of inflammatory and immunoregulatory mediators (e.g., TNFα, IL-10, TGFβ, IL-15) post-HCT.

Main Results:

  • Risk for chronic GVHD is linked to genetic polymorphisms and deficiencies in regulatory immune cells.
  • Established chronic GVHD involves altered immune cell profiles and perturbed inflammatory mediators.
  • Specific markers like TNFα, IL-10, BAFF, and deficiencies in Treg and NK cells are implicated.

Conclusions:

  • Biologic markers offer insights into chronic GVHD pathogenesis and potential therapeutic targets.
  • Further validation of candidate markers in independent populations is needed.
  • Knowledge gaps remain regarding markers for phenotype, severity, and treatment response.